A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Jerby-Arnon, Livnat, Shah, Parin, Cuoco, Michael S., Rodman, Christopher, Su, Mei-Ju, Melms, Johannes C., Leeson, Rachel, Kanodia, Abhay +44 more·2018·Cell

DOI 10.1016/j.cell.2018.09.006

Cited by (999)

Items 801–900 of 999

Leveraging high-resolution omics data for predicting responses and adverse events to immune checkpoint inhibitors
Angelo Limeta, Francesco Gatto, Markus J. Herrgård, Boyang Ji, Jens Nielsen · 2023 · Computational and Structural Biotechnology Journal
A Comprehensive Benchmark of Transcriptomic Biomarkers for Immune Checkpoint Blockades
Hongen Kang, Xiuli Zhu, Ying Cui, Zhuang Xiong, Wenting Zong, Yīmíng Bào, Peilin Jia · 2023 · Cancers
Molecular Susceptibility and Treatment Challenges in Melanoma
Prathvi V. Shenoy, Radhakanta Nag, Kiran Kumar Kolathur, Yagya Malik, Sai Manasa Varanasi, Ramcharan Singh Angom, Debabrata Mukhopadhyay · 2024 · Cells
A Distinguished Roadmap of Fibroblast Senescence in Predicting Immunotherapy Response and Prognosis Across Human Cancers
Dongjie Chen, Pengyi Liu, Jiayu Lin, Longjun Zang, Yihao Liu, Shuyu Zhai, Xiongxiong Lu, Yuanchi Weng, Hongzhe Li · 2024 · Advanced Science
4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy
Junha Cha, Chang Gon Kim, Nam Suk Sim, Gamin Kim, Wonrak Son, Dahee Kim, Yurim Jung, Hyun Jun Hong, Hae Been Lee, Jaehyung Kim et al. · 2025 · Cell Reports Medicine
Single-Cell Technologies to Decipher the Immune Microenvironment in Myeloid Neoplasms: Perspectives and Opportunities
Chiara Caprioli, Iman Nazari, Sara Milovanovic, Pier Giuseppe Pelicci · 2022 · Frontiers in Oncology
The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia
Adi Nagler, Catherine J. Wu · 2022 · Blood
Detection of somatic copy number deletion of the CDKN2A gene by quantitative multiplex PCR for clinical practice
Yuan Tian, Jing Zhou, Juanli Qiao, Zhaojun Liu, Liankun Gu, Baozhen Zhang, Youyong Lu, Rui Xing, Dajun Deng · 2022 · Frontiers in Oncology
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors
Dingwei Ye, Jayesh Desai, Jingwen Shi, Si‐Yang Maggie Liu, Wei Shen, Tengfei Liu, Yang Shi, Dan Wang, Liang Liang, Silu Yang et al. · 2023 · Biomarker Research
A new approach to overcoming resistance to immunotherapy: nanotechnology
Jiangbo Shao, Ying Hui Jin, Chunxiang Jin · 2023 · Frontiers in Oncology
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer
Xiaohe Su, Kaifeng Jin, Qiji Guo, Ziyue Xu, Zhaopei Liu, Han Zeng, Yiwei Wang, Yu Zhu, Le Xu, Zewei Wang et al. · 2024 · British Journal of Cancer
SDePER: a hybrid machine learning and regression method for cell-type deconvolution of spatial barcoding-based transcriptomic data
Yunqing Liu, Ningshan Li, Ji Qi, Gang Xu, Jiayi Zhao, Nating Wang, Xiayuan Huang, Wenhao Jiang, Huanhuan Y. Wei, A. Justet et al. · 2024 · Genome biology
Interferon-induced factor 16 is essential in metastatic melanoma to maintain STING levels and the immune responses upon IFN-γ response pathway activation
Yuta Kobayashi, Matias Alberto Bustos, Yoshinori Hayashi, Qiang Yu, Dave S.�B. Hoon · 2024 · Journal for ImmunoTherapy of Cancer
Multimodal diagnostic models and subtype analysis for neoadjuvant therapy in breast cancer
Zheng Ye, Jiaqi Yuan, Deqing Hong, Peng Xu, Wenbin Liu · 2025 · Frontiers in Immunology
Single-cell transcriptome analysis of the heterogeneous effects of differential expression of tumor PD-L1 on responding TCR-T cells
Renpeng Ding, Shang Liu, Shanshan Wang, Huanyi Chen, Fei Wang, Qumiao Xu, Linnan Zhu, Xuan Dong, Ying Gu, Xiuqing Zhang et al. · 2021 · Theranostics
Evaluation of single-cell RNA-seq clustering algorithms on cancer tumor datasets
Alaina Mahalanabis, Andrei L. Turinsky, Mia Husić, Erik Christensen, Ping Luo, Alaine Naidas, Michael Brudno, Trevor J. Pugh, Arun K Ramani, Parisa Shooshtari · 2022 · Computational and Structural Biotechnology Journal
An individualized causal framework for learning intercellular communication networks that define microenvironments of individual tumors
Xueer Chen, Lujia Chen, Cornelius H. L. Kürten, Fattaneh Jabbari, Lazar N. Vujanovic, Ying Ding, Binfeng Lu, Kevin Lu, Aditi Kulkarni, Tracy Tabib et al. · 2022 · PLoS Computational Biology
National Cancer Institute Think-Tank Meeting Report on Proteomic Cartography and Biomarkers at the Single-Cell Level: Interrogation of Premalignant Lesions
Jacob Kagan, Robert L. Moritz, Richard V. Mazurchuk, Je Hyuk Lee, Peter V. Kharchenko, Orit Rozenblatt–Rosen, Eytan Ruppin, Fredrik Edfors, Fiona Ginty, Yury Goltsev et al. · 2020 · Journal of Proteome Research
Pan-cancer mapping of single T cell profiles reveals a TCF1:CXCR6-CXCL16 regulatory axis essential for effective anti-tumor immunity
Livnat Jerby‐Arnon, Katherine Tooley, Giulia Escobar, Gitanjali Dandekar, Asaf Madi, Ella Goldschmidt, Conner Lambden, Orit Rozenblatt–Rosen, Ana Carrizosa Anderson, Aviv Regev · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD)
Fang Lv, Xueying Wu, Jin Sook Song, Pan Wang, Shucheng Ren, Wei Guo, Qi Xue, Henghui Zhang, Jun Zhao · 2021 · Biomarker Research
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)
Alexander Z. Wei, Lanyi Nora Chen, Marlana M. Orloff, Charlotte Eielson Ariyan, Maryam M. Asgari, Christopher Andrew Barker, Elizabeth Iannotti Buchbinder, Sunandana Chandra, Kasey L. Couts, Michael M. Frumovitz et al. · 2023 · Pigment Cell & Melanoma Research
Pulsed electric field induces exocytosis and overexpression of MAGE antigens in melanoma
Wojciech Szlasa, Natalia Julia Sauer, Dagmara Baczyńska, Marcin Ziętek, Katarzyna Haczkiewicz-Leśniak, Paweł Karpiński, Mariusz G. Fleszar, Paulina Fortuna, Michał Kulus, Aleksandra Piotrowska et al. · 2024 · Scientific Reports
Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma
Trang Thi Thu Nguyen, Qiuqiang Gao, Jeong-Yeon Mun, Zhe Zhu, Chang Shu, Aaron Naim, Meri Rogava, Benjamin Izar, Mike‐Andrew Westhoff, Georg Karpel‐Massler et al. · 2024 · Cells
A recent perspective on designing tumor vaccines for tumor immunology
Shougen Cao, Wenyu Jia, Yifan Zhao, Heng Liu, Jie Cao, Zequn Li · 2024 · International Immunopharmacology
Distinct follicular T cell subsets regulate lymphoma progression and outcomes
Yoshiaki Abe, Junko Zenkoh, Akinori Kanai, Daisuke Ikeda, Daisuke Kaji, Aya Sawa, Ryota Matsuoka, Kei Asayama, Rikako Tabata, Ryota Ishii et al. · 2025 · Cancer Cell
Single-cell transcriptomics reveals hypoxia-driven iCAF_PLAU is associated with stemness and immunosuppression in anorectal malignant melanoma
Hao Zhang, Lin Gan, Xiaofei Duan, Baojing Tuo, Hao Zhang, Senbo Liu, Yugui Lian, Enjie Liu, Zhenqiang Sun · 2025 · Journal of Gastroenterology
Targeting Senescence in Oncology: An Emerging Therapeutic Avenue for Cancer
Satoru Meguro, Syunta Makabe, Kei Yaginuma, Akifumi Onagi, Ryo Tanji, Kanako Matsuoka, Seiji Hoshi, Tomoyuki Koguchi, Emina Kayama, Junya Hata et al. · 2025 · Current Oncology
Focal Adhesion Kinase-Dependent Reprogramming of IFN-γ Signaling through PYK2 Coinhibition Sensitizes Melanoma to Immune Checkpoint Blockade
Yuto Mizuno, Masanari Umemura, Akane Nagasako, Tomoko Hayashi Akiyama, Momoko Nagai, Jo Nishino, Jordan A. Ramilowski, Yayoi Kimura, Mamoru Kato, Yukie Yamaguchi et al. · 2025 · Journal of Investigative Dermatology
From chronic inflammation to immune escape: mapping the tumor microenvironment evolution in renal cell carcinoma
Haisheng Xu, Bo Tu, Hui Li, Yong Shan · 2025 · Frontiers in Immunology
MYC at the tumor–immune interface: mechanisms of immune escape and immunotherapy resistance
Íñigo González-Larreategui, M. C. Martin, Sílvia Casacuberta‐Serra, Laura Soucek · 2026 · Frontiers in Immunology
Proteasome-guided haem signalling axis contributes to T cell exhaustion
Yingxi Xu, Yangtao Shangguan, Yu‐Ming Chuang, Tzu-Hsuan Chang, Wenbing Liu, Jhan-Jie Peng, Josep Garnica, Leling Xie, Pei‐Chun Hsueh, Mei-Chun Lin et al. · 2026 · Nature
Adaptive resistance in cancer immunotherapy
K E Yang, Chunqian Yang, Kai Xiong, Jiangtao Hao, Lilin Ye · 2026 · Cellular and Molecular Immunology
Uncovering spatially resolved functional genomics with CRISPR screen sequencing
Haorui Zhang, Zongxu Zhang, Peiyu Wang, Tian Xu, Xiaoyu Chen, Yanping Zhao, Siyu Lin, Wenjie Cai, Pengfei Ren, Ce Luo et al. · 2026 · Cell
Transcriptomic signatures of tumors undergoing T cell attack
Aishwarya Gokuldass, Aimilia Schina, Martin Lauss, Katja Harbst, Christopher Aled Chamberlain, Arianna Draghi, Marie Christine Wulff Westergaard, Morten Nielsen, Krisztián Papp, Zsófia M. Sztupinszki et al. · 2021 · Cancer Immunology Immunotherapy
Brain Microenvironment Heterogeneity: Potential Value for Brain Tumors
Laura Álvaro‐Espinosa, Ana de Pablos-Aragoneses, Manuel Valiente, Neibla Priego · 2021 · Frontiers in Oncology
The (re)discovery of tumor-intrinsic determinants of immune sensitivity by functional genetic screens
David W. Vredevoogd, Georgi Apriamashvili, Daniel S. Peeper · 2021 · Immuno-Oncology Technology
Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6+ CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma
Xiaogang Li, Zheng Gao, Jiafeng Chen, Shanru Feng, Xuanming Luo, Ying–Hong Shi, Zheng Tang, Weiren Liu, Xin Zhang, Ao Huang et al. · 2023 · Frontiers in Oncology
Senescence-related genes analysis in breast cancer reveals the immune microenvironment and implications for immunotherapy
Hua Zhong, Lijie Chang, Shengbin Pei, Yakun Kang, Lili Yang, Yifan Wu, Nuo Chen, Yicheng Luo, Yixiao Zhou, Jiaheng Xie et al. · 2024 · Aging
Targeting tumor-intrinsic S100 calcium-binding protein A1 augments antitumor immunity and potentiates immunotherapy efficacy
Yufeng Guo, R. Wan, J. Duan, Li Yuan, Zhi-Jie Wang, Jia Zhong, Xue Zhang, Zixiao Ma, Hua Bai, Jie Wang · 2025 · Signal Transduction and Targeted Therapy
Optimizing TIL therapy for uveal melanoma: lessons learned and unlearned from cutaneous melanoma
Shravan Leonard‐Murali, Udai S. Kammula · 2025 · Immunotherapy
Desmosome mutations impact the tumor microenvironment to promote melanoma proliferation
Maayan Baron, Mohita M. Tagore, Patrick Wall, Fan Zheng, Dalia Barkley, Itai Yanai, Jing Yang, Maija H. Kiuru, Richard Mark White, Trey E. Ideker · 2025 · Nature Genetics
Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment
Naixue Yang, Fansen Ji, Liqing Cheng, Jingzhe Lu, Xiaofeng Sun, Xin Lin, Xun Lan · 2021 · npj Precision Oncology
Analysis of Melanoma Gene Expression Signatures at the Single-Cell Level Uncovers 45-Gene Signature Related to Prognosis
Mohamed Nabil Bakr, Haruko Takahashi, Yutaka Kikuchi · 2022 · Biomedicines
Single-Cell Sequencing Yields Insights in the Evolution of Foot-and-Mouth Disease Virus Persistent Infection
Yuncong Yuan, Xingran Wang, Jiadai Li, Lingling Han, Hang Du, Yidan Sun, Pu Yang, Zhou Zhou, Meijia Gu, Yang Lu et al. · 2022 · Frontiers in Cellular and Infection Microbiology
Combining single-cell and transcriptomic analysis revealed the immunomodulatory effect of GOT2 on a glutamine-dependent manner in cutaneous melanoma
Lebin Song, Xiyi Wei, Xi Zhang, Yan Lu · 2023 · Frontiers in Pharmacology
Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors
Keller Toral, Mark A. Wuenschel, Esther P. Black · 2021 · PLoS ONE
Single-cell RNA sequencing reveals a novel cell type and immunotherapeutic targets in papillary thyroid cancer
Zhengshi Wang, Youlutuziayi Rixiati, Wen‐Li Jiang, Chen Ye, Caiguo Huang, Chuangang Tang, Zhiqiang Yin, Binghua Jiao · 2021 · medRxiv
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer–testis antigen PRAME
Ana R Ribeiro, Camille Britton-Rivet, Laura C. Collins, Ricardo J. Carreira, Sylvie Moureau, Adel Benlahrech, Sarah Stanhope, Stephen J Harper, Nathaniel Liddy, Tara Mahon et al. · 2024 · Immunotherapy Advances
Alternate actions of CDK4/6 inhibitors beyond cell cycle blockade: unexplored roles in therapy resistance
Domenica Scordamaglia, Marianna Talia, Azzurra Zicarelli, Adelina Assunta Mondino, Salvatore De Rosis, Marika Di Dio, Francesca Silvestri, Chiara Meliti, Francesca Cirillo, Ernestina Marianna De Francesco et al. · 2025 · Cancer and Metastasis Reviews
GBP2 condensates promote ferroptosis to sensitize anti-PD-L1 immunotherapy in melanoma
Xin Liu, Shilin Fang, Xianghai Ren, Yuntian Hong, Jianchun Guo, Xiaoping Liu, Liping Gao, Haihang Nie, Yumei Ning, Meng Zhang et al. · 2025 · Nature Communications
Slow Transcription of the 99a/let-7c/125b-2 Cluster Results in Differential MiRNA Expression and Promotes Melanoma Phenotypic Plasticity
Danna Sheinboim, Shivang Parikh, Roma Parikh, Amitai Menuchin, Guy Shapira, Oxana Kapitansky, Nadav Elkoshi, Shmuel Ruppo, Lital Shaham, Tamar Golan et al. · 2021 · Journal of Investigative Dermatology
The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer
Jiangti Luo, Canping Chen, Zhixian Liu, Xiaosheng Wang · 2023 · Frontiers in Cell and Developmental Biology
Chromosome 11q13 amplification correlates with poor response and prognosis to PD-1 blockade in unresectable hepatocellular carcinoma
Kai Yan, Ding Zhang, Yanan Chen, Wenfeng Lu, Mengli Huang, Jinping Cai, Shiqing Chen, Ting Bei, Yuezong Bai, Jian Lv et al. · 2023 · Frontiers in Immunology
Immune cell type signature discovery and random forest classification for analysis of single cell gene expression datasets
Bogac Aybey, Sheng Zhao, Benedikt Brors, Eike Staub · 2023 · Frontiers in Immunology
PANoptosis ‐related signature in melanoma: Transcriptomic mapping and clinical prognostication
Jiaheng Xie, Pengpeng Zhang, Xiaolong Xu, Xinxin Zhou, Songyun Zhao, Min Zhang, Min Qi · 2024 · Environmental Toxicology
Machine learning-derived immunosenescence index for predicting outcome and drug sensitivity in patients with skin cutaneous melanoma
Linyu Zhu, Lvya Zhang, Junhua Qi, Zhiyu Ye, Gang Nie, Shaolong Leng · 2024 · Genes and Immunity
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma
Jan‐Malte Placke, Jenny Bottek, Renáta Váraljai, Batool Shannan, Sarah Scharfenberg, Christoph Krisp, Philippa Spangenberg, Camille Soun, Devon Siemes, Lars Borgards et al. · 2024 · British Journal of Dermatology
Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi-omics data, integrated machine learning, and experimental validation
Jiajun Li, Nuo Xu, Leyin Hu, Jiayue Xu, Yifan Huang, Deqi Wang, Feng Chen, Yi Wang, Jiani Jiang, Yanggang Hong et al. · 2025 · Cancer Immunology Immunotherapy
Techniques for Profiling the Cellular Immune Response and Their Implications for Interventional Oncology
Tushar Garg, Clifford R. Weiss, Rahul A. Sheth · 2022 · Cancers
Retinoblastoma-Binding Protein 5 Regulates H3K4 Methylation Modification to Inhibit the Proliferation of Melanoma Cells by Inactivating the Wnt/β-Catenin and Epithelial-Mesenchymal Transition Pathways
Zhiqin Yang, Yue Jia, Shaojia Wang, Yongjun Zhang, Wen Fan, Xin Wang, Liang He, Xiaoyu Shen, Xiangqun Yang, Yi Zhang et al. · 2023 · Journal of Oncology
Mapping multicellular programs from single-cell profiles
Livnat Jerby‐Arnon, Aviv Regev · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy
Or‐Yam Revach, Angelina M. Cicerchia, Ofir Shorer, Boryana Petrova, Seth Anderson, Joshua C. Park, Lee Chen, Arnav Mehta, Samuel J. Wright, Niamh McNamee et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Cancer specific up-regulated lactate genes associated with immunotherapy resistance in a pan-cancer analysis
Shuiting Fu, Jiachen Xu, Chunming Wang, Cheng Zhang, Chengcheng Li, Wenchuan Xie, Guoqiang Wang, Xin Zhu, Yuyan Xu, Yaohong Wen et al. · 2024 · Heliyon
Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer
Fengjie Lin, Hanxuan Yang, Zongwei Huang, Ying Li, Qin Ding, Yunbin Ye, Sufang Qiu · 2024 · Frontiers in Pharmacology
STModule: identifying tissue modules to uncover spatial components and characteristics of transcriptomic landscapes
Ran Wang, Qian Yan, Xiaojing Guo, Fangda Song, Zhiqiang Xiong, Shirong Cai, Xiuwu Bian, Man Hon Wong, Qin Cao, Lixin Cheng et al. · 2025 · Genome Medicine
B cell extracellular vesicles influence melanoma response to immune checkpoint therapy
Ala’a Al Hrout, Agshin Balayev, Karla Cervantes-Gracia, Konstantinos Gkelis, Stephan Benke-Bruderer, Julia M. Martínez Gómez, Karīna Siliņa, Mitchell Paul Levesque, Richard Chahwan · 2025 · Science Advances
Quantitative profiling of intratumor immune heterogeneity identifies loss of immune diversity as a hallmark of cancer progression
Qiqi Lu, Jiangti Luo, Chia-Hao Tung, Xiaosheng Wang, Zhongming Zhao · 2025 · npj Precision Oncology
RAS/MEK/PI3K pathway inhibition augments response to CD40 agonism by targeting CD11b+ Bregs thereby overcoming melanoma PD1-resistance
Chi Wing Yan, Weifeng Luo, Jinming Yang, Jing Yang, Sheau‐Chiann Chen, Kensey N. Bergdorf, Qianni Hu, Vivian Lee Weiss, Douglas Buckner Johnson, Qi Liu et al. · 2026 · Nature Communications
Oral microbiome-SASP-aging axis: mechanisms and targeted intervention strategies for age-related diseases
Enfang Wu, Xueyu Li, Zichen Ni, Feng Zhao, Chen Jia · 2026 · Journal of Oral Microbiology
Rewiring melanoma cell fate: TRPM8 modulators trigger apoptosis and boost NK cell cytotoxicity
Carmela Sorrentino, Carmine Lauretta, Rosa D’Angiolo, Simona Musella, Pia Giovannelli, Alessia Bertamino, Carmine Ostacolo, Isabel Gomez Monterrey, Antimo Migliaccio, Gabriella Castoria et al. · 2026 · Cell Death and Disease
Single-cell and spatial profiling in cancer biology and clinical oncology
Chris J. Frangieh, Joy Linyue Fan, Johannes C. Melms, Parin Shah, Elham Azizi, Benjamin Izar · 2026 · Nature Cancer
Single-cell profiling to transform immunotherapy usage and target discovery in immune-mediated inflammatory diseases
Nicolas Chapelle, Aurelie Fantou, Thomas Marron, Ephraim Kenigsberg, Miriam Mérad, Jerome C. Martin · 2022 · Frontiers in Immunology
Impaired expression of serine/arginine protein kinase 2 (SRPK2) affects melanoma progression
Mônica Maria Magalhães Caetano, Gabriela Alves Moreira, Maria Roméria da Silva, Gabriela Rapozo Guimarães, Leandro de Oliveira Santos, Amanda de Ambrósio Pacheco, Raoni Pais Siqueira, Flávia Carneiro Mendes, Eduardo De Almeida Marques Da Silva, Abelardo Silva‐Júnior et al. · 2022 · Frontiers in Genetics
Dissecting cellular states of infiltrating microenvironment cells in melanoma by integrating single-cell and bulk transcriptome analysis
Aiai Shi, Min Yan, Bo Pang, Lin Pang, Yihan Wang, Yujia Lan, Xinxin Zhang, Jinyuan Xu, Yanyan Ping, Jing Rong Hu · 2023 · BMC Immunology
Leveraging a KRAS-based signature to predict the prognosis and drug sensitivity of colon cancer and identifying SPINK4 as a new biomarker
Jian-Ting Huo, Abudumaimaitijiang Tuersun, Su-Yue Yu, Yuchen Zhang, Wenqing Feng, Zhuoqing Xu, Jingkun Zhao, Yaping Zong, Aiguo Lu · 2023 · Scientific Reports
Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response
Shanshan Li, Junjie Zhao, Guangyu Wang, Qingping Yao, Zhe Leng, Qinglei Liu, Jun Jiang, Wei Wang · 2024 · Archives of Dermatological Research
Single-Cell Profiling of Sarcomas from Archival Tissue Reveals Programs Associated with Resistance to Immune Checkpoint Blockade
Karan D. Luthria, Parin Shah, Blake Caldwell, Johannes C. Melms, Sinan Abuzaid, Viktoria Jakubikova, D. Zack Brodtman, Sminu Bose, Amit Dipak Amin, Patricia Ho et al. · 2024 · Clinical Cancer Research
Integrated multiomics revealed adenosine signaling predict immunotherapy response and regulate tumor ecosystem of melanoma
Yantao Xu, Poyee Lau, Xiang Chen, Shuang Zhao, Yi He, Zixi Jiang, Xiang Chen, Guanxiong Zhang, Hong Liu · 2024 · Human Genomics
Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy
Marcella Willemsen, Jenny Bulgarelli, Sudhir Kumar Chauhan, Ragnhild Reehorst Lereim, Davide Angeli, G. Grisendi, Gabrielle Krebbers, Irwin Davidson, Jon Amund Kyte, Massimo Guidoboni et al. · 2024 · Immuno-Oncology Technology
TCGEx: a powerful visual interface for exploring and analyzing cancer gene expression data
Muhammet Emre Kus, Cagatay Sahin, Emre Kılıç, Arda Askin, M Mert Ozgur, Gokhan Karahanogullari, Ahmet Aksit, Ryan M. O’Connell, H. Atakan Ekiz · 2025 · EMBO Reports
Current state of cancer immunity cycle: new strategies and challenges of using precision hydrogels to treat breast cancer
Yingze Zhu, Yanlin Su, Yaxin Guo, Xinyue Wang, Zhuoqi Zhang, Yu Lu, Hang Yang, Hui Pang · 2025 · Frontiers in Immunology
NEDDylation Regulates CD8+ T-cell Metabolism and Antitumor Immunity
Borja Jiménez-Lasheras, Paloma Velasco-Beltrán, Leire Egia‐Mendikute, Lorena Pérez, So Young Lee, Ander de Blas, Ana García-del Río, Samanta Romina Zanetti, Asier Antoñana-Vildosola, Adrián Barreira-Manrique et al. · 2025 · Cancer Immunology Research
Lipid nanoparticle-delivered IFNα2 activates Cxcl9 to increase T cell tumor recruitment to suppress lung metastasis
Kendra Fick, Nicholas Kerns, Yang Zhao, Zainab Tiamiyu, Dakota B Poschel, Patrick Czabala, Da-Feng Yang, Yi Tang, Jin Xie, V. Fesenkova et al. · 2025 · Journal for ImmunoTherapy of Cancer
Pan‐cancer analysis of altered glycosyltransferases confers poor clinical outcomes
Saravanakumar Marimuthu, Surinder K. Batra, Moorthy Palanimuthu Ponnusamy · 2022 · Clinical and Translational Discovery
B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas
Min Hsu, Tiphaine C. Martin, Nikki S. Vyas, Garrett T. Desman, Karen Mendelson, Basil A. J. Horst, Ramon E. Parsons, Julide Tok Celebi · 2023 · Pigment Cell & Melanoma Research
From patient tissue correlates to molecular mechanisms of cancer immune evasion: the emerging role of CD58 and PD-L1 co-regulation via CMTM6
Johannes C. Melms, Patricia Ho, Meri Rogava, Benjamin Izar · 2023 · Genes and Immunity
Global pannexin 1 deletion increases tumor‐infiltrating lymphocytes in the BRAF /Pten mouse melanoma model
Rafael E. Sanchez‐Pupo, Garth A. Finch, Danielle E. Johnston, Heather C. Craig, Rober Abdo, Kevin Barr, Steven M. Kerfoot, Lina Dagnino, Silvia Peñuela · 2024 · Molecular Oncology
PREDICTIVE RESPONSE MARKERS FOR IMMUNE RESPONSE BLOCKS
Grigorii A. Janus, Aglaya G. Iyevleva, Evgeny N. Suspitsyn, Vladislav I. Tiurin, Бизин Илья Валерьевич, Olga A. Gorustovich, E. Imyanitov, Maksim M. Kholmatov, Tatiana A. Laidus, Svetlana Chuynyshena et al. · 2020 · Siberian Journal of Oncology
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8 + T cells
Elisa Matas-Rico, Elselien Frijlink, Irene van der Haar Àvila, Apostolos Menegakis, Maaike van Zon, Andrew J. Morris, Jan Köster, Fernando Salgado-Polo, Sander de Kivit, Telma Lança et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Targeting of TP53-independent cell cycle checkpoints overcomes FOLFOX resistance in Metastatic Colorectal Cancer
Corina Behrenbruch, Momeneh Foroutan, Phoebe Lind, Jai Smith, Mélodie Grandin, Benjamin Cooper, Carolyn Shembrey, Susanne Ramm, Karla J. Cowley, Iva Nikolić et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Cystatin C is glucocorticoid-responsive, directs recruitment of Trem2+ macrophages and predicts failure of cancer immunotherapy
Sam O. Kleeman, Breanna R. Demestichas, Nicholas Mourikis, Dominik Loiero, Miriam Ferrer, Sean Bankier, Yosef Joseph Rene Amel Riazat‐Kesh, Hassal Lee, Dimitrios Chantzichristos, Claire Regan et al. · 2021 · medRxiv
Graph neural networks learn emergent tissue properties from spatial molecular profiles
David S. Fischer, Mayar Ali, Sabrina Richter, Ali Ertürk, Fabian Joachim Theis · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
SORBET: Automated cell-neighborhood analysis of spatial transcriptomics or proteomics for interpretable sample classification via GNN
Shay Shimonov, Joseph M Cunningham, Ronen Talmon, Lilach Aizenbud, Shruti J Desai, David L. Rimm, Kurt Alex Schalper, Harriet M. Kluger, Yuval Kluger · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Integrated cancer cell-specific single-cell RNA-seq datasets of immune checkpoint blockade-treated patients
M. Gondal, M. Cieslik, A. Chinnaiyan · 2024 · bioRxiv
Integration of single-cell and bulk RNA sequencing data reveals that CYTOR is a potential prognostic and immunotherapeutic response marker for skin cutaneous melanoma
Ming Zhang, Yikun Ju, Lei Xue, Xueheng Zhao, Xuezheng Xu, Geng Wu, Hao Bo, Zailong Qin · 2024 · Journal of Cancer
Defining Non–small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World Data
Lang Ho Lee, Xin Xu, Thanos P. Mourikis, Fanying Tang, Lauren Fairchild, Lexiang Ji, Angelo L. Grauel, Joel P. Wagner, Sebastian Szpakowski, Marc R. Pelletier et al. · 2025 · Cancer Research Communications
Integrated multi-omics analysis reveals a glycolytic signature that predicts pan-cancer immune checkpoint inhibitor response and LDHA as a combinatorial target in fumarate hydratase-deficient renal cell carcinoma
Songyang Liu, Yunlong Yuan, Junzhe He, Yihan Zhou, Yuan Wang, Xinqi Ye, Jianfeng Wang, Jin Zhang · 2025 · Frontiers in Immunology
Overcoming conditional immune resistance in MSS and pMMR colorectal cancer: A sequential gating framework for immunotherapy
Husni S. Farah, Djamila Polatova, Jasur Rizaev, Faez Ahmed Mhdy, Faris Anad Muhammad, Laxmidhar Maharana, Neeraj Bainsal, Ritesh Singh · 2026 · Critical Reviews in Oncology/Hematology
Iron overload in the tumor microenvironment induces CD8+ T cell ferroptosis and dysfunction
Zhenyu Lin, CHEN Huanpeng, Yujing Ke, Hanyue Xiao, Chao Li, Zilong Wu, Huixin Gao, Nanqi Huang, Lijuan Lu, Peng Sun et al. · 2026 · Nature Communications
Separate and Mutual Effects of BIRB796 and Bortezomib on pHsp27 and Viability of U87MG Glioma Cells
Sevde Nur Biltekin, Evren Önay Uçar · 2023 · Biology Bulletin